ReviewActa pharmacologica Sinica2022

Engineered nanomedicines block the PD-1/PD-L1 axis for potentiated cancer immunotherapy.

Jun-Hao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.